4th Edition of International Precision Medicine Conference
August 17-19, 2023 | Online Event
Product Development and Commercialization Challenges
Product development entails the creation of a high-quality product as well as the development of manufacturing methods that ensure consistent production of that product. In comparison to other businesses, developing new products in the pharmaceutical industry is a far more complicated procedure. The expense of development, R&D capability, ministry of health registration, and raw material sourcing all make this a difficult assignment for any marketing team. Acquisition, one of the most common techniques of acquiring new products, is not appropriate for local pharmaceutical enterprises in poor nations. Given the size and resources accessible to local business, there is currently no way to develop original items. Unmet clinical need should have been discovered throughout product development.
- Policies
- Market Trends
- Molecule Identification
- Molecule Screening
- Marketing Strategy Development
Bernd Blobel
University of Regensburg, Germany
Roy Gary Beran
University of New South Wales, Australia
Matthias Schwab
University of Tubingen, Germany
Thomas Webster
Interstellar Therapeutics, United States
Boris Tankhilevich
Magtera, Inc., United States
Isabella Friis Jorgensen
University of Copenhagen, Denmark
Guo Wei He
Tianjin University, ChinaSubmit your abstract Today
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Personalized and precision medicine (PPM) can be established as a unique healthcare model through biodesign-driven and inspired biotech, translational applications. This approach aims to ensure human healthcare, wellness, and biosafety.
Sergey Suchkov, Institute for Biotech & Global Health of RosBioTech and A.I. Evdokimov MGMSU, Russian Federation
Title : Monitoring folds localization in ultra-thin transition metal dichalcogenides using optical harmonic generation
Ahmed Raza Khan, Australian National University, Australia
Title : A systematic review of regulatory approaches for Direct- To- Consumers (DTC) genetic testing
Kavitha Palaniappan, Duke-NUS Medical School, Singapore
Title : Regulatory framework of in vitro diagnostic and artificial intelligence for precision medicine
Pei Ting Sarah Chou, Regulatory Affairs Professionals Society, Taiwan
Title : Unraveling cancer stem cell signatures in circulating tumor cells of metastatic colorectal cancer: Investigating ALDH1A1 and the repurposing potential of disulfiram via scRNA-seq
Nurul Syakima Ab Mutalib, Universiti Kebangsaan Malaysia, Malaysia